Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?

Cunningham C, Skelly DT.

J Neuroimmune Pharmacol. 2012 Mar;7(1):60-73. doi: 10.1007/s11481-011-9312-5. Epub 2011 Sep 20. Review.

2.

Systemic inflammation and delirium: important co-factors in the progression of dementia.

Cunningham C.

Biochem Soc Trans. 2011 Aug;39(4):945-53. doi: 10.1042/BST0390945. Review.

4.

Neuroinflammatory challenges compromise neuronal function in the aging brain: Postoperative cognitive delirium and Alzheimer's disease.

Cortese GP, Burger C.

Behav Brain Res. 2017 Mar 30;322(Pt B):269-279. doi: 10.1016/j.bbr.2016.08.027. Epub 2016 Aug 17. Review.

5.

Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research.

Cunningham C, Hennessy E.

Alzheimers Res Ther. 2015 Mar 24;7(1):33. doi: 10.1186/s13195-015-0117-2. eCollection 2015.

6.

Cyclooxygenase-1-dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction.

Griffin ÉW, Skelly DT, Murray CL, Cunningham C.

J Neurosci. 2013 Sep 18;33(38):15248-58. doi: 10.1523/JNEUROSCI.6361-11.2013.

7.

Dual acting anti-inflammatory drugs: a reappraisal.

Bertolini A, Ottani A, Sandrini M.

Pharmacol Res. 2001 Dec;44(6):437-50. Review.

PMID:
11735348
8.

Drug-induced cognitive impairment in the elderly.

Moore AR, O'Keeffe ST.

Drugs Aging. 1999 Jul;15(1):15-28. Review.

PMID:
10459729
9.

Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials.

Gorelick PB.

Ann N Y Acad Sci. 2010 Oct;1207:155-62. doi: 10.1111/j.1749-6632.2010.05726.x. Review.

PMID:
20955439
10.
11.

Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.

Jaturapatporn D, Isaac MG, McCleery J, Tabet N.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD006378. doi: 10.1002/14651858.CD006378.pub2. Review.

PMID:
22336816
12.

Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.

Sanchez-Ramos J, Song S, Sava V, Catlow B, Lin X, Mori T, Cao C, Arendash GW.

Neuroscience. 2009 Sep 29;163(1):55-72. doi: 10.1016/j.neuroscience.2009.05.071. Epub 2009 Jun 14.

PMID:
19500657
13.

[Drug-induced Cognitive Impairment].

Shinohara M, Yamada M.

Brain Nerve. 2016 Apr;68(4):421-8. doi: 10.11477/mf.1416200415. Review. Japanese.

PMID:
27056860
14.

Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation.

Lee JW, Lee YK, Yuk DY, Choi DY, Ban SB, Oh KW, Hong JT.

J Neuroinflammation. 2008 Aug 29;5:37. doi: 10.1186/1742-2094-5-37.

15.

Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.

Hoozemans JJ, Veerhuis R, Rozemuller JM, Eikelenboom P.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):57-67. Review.

PMID:
21143138
16.

Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample.

Ramos-Miguel A, Hercher C, Beasley CL, Barr AM, Bayer TA, Falkai P, Leurgans SE, Schneider JA, Bennett DA, Honer WG.

Mol Neurodegener. 2015 Dec 2;10:65. doi: 10.1186/s13024-015-0061-4.

17.

Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms.

Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, Capurso A, Panza F.

Ageing Res Rev. 2010 Apr;9(2):184-99. doi: 10.1016/j.arr.2009.07.005. Epub 2009 Jul 28. Review.

PMID:
19643207
18.

GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice.

Boyd TD, Bennett SP, Mori T, Governatori N, Runfeldt M, Norden M, Padmanabhan J, Neame P, Wefes I, Sanchez-Ramos J, Arendash GW, Potter H.

J Alzheimers Dis. 2010;21(2):507-18. doi: 10.3233/JAD-2010-091471.

19.

Worsening cognitive impairment and neurodegenerative pathology progressively increase risk for delirium.

Davis DH, Skelly DT, Murray C, Hennessy E, Bowen J, Norton S, Brayne C, Rahkonen T, Sulkava R, Sanderson DJ, Rawlins JN, Bannerman DM, MacLullich AM, Cunningham C.

Am J Geriatr Psychiatry. 2015 Apr;23(4):403-15. doi: 10.1016/j.jagp.2014.08.005. Epub 2014 Aug 15.

20.

Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients.

van den Boogaard M, Kox M, Quinn KL, van Achterberg T, van der Hoeven JG, Schoonhoven L, Pickkers P.

Crit Care. 2011;15(6):R297. doi: 10.1186/cc10598. Epub 2011 Dec 29.

Supplemental Content

Support Center